Pharma Deutschland e.V. is the largest pharmaceutical industry association in Germany, representing over 400 member companies. The organization focuses on advocacy, providing expert advice, publications, seminars, and member services to support the pharmaceutical sector. The website reflects a professional and well-structured digital presence, targeting industry stakeholders, policymakers, and the public. It offers multilingual support and a member login area, enhancing engagement and service delivery. Technically, the site is built on TYPO3 CMS, hosted on rzone.de infrastructure, and integrates modern tools such as Usercentrics for consent management and Matomo for privacy-conscious analytics. Security posture is strong with HTTPS enforcement and secure login mechanisms, though some security headers could be improved. Privacy compliance is robust, with clear GDPR-aligned policies and cookie consent mechanisms. Overall, the site demonstrates high business credibility and trustworthiness, with transparent contact information and active social media channels.
Scanned ·
NIS2 and GDPR posture
GDPR outside view
68/ 100 · Medium
Checks completed
7of 7
NIS2 Art. 21(2)
a(a) Risk analysis and security policies: Not visible from outside
b(b) Incident handling: One indicator
c(c) Business continuity, backups and crisis management: Not visible from outside
d(d) Supply chain security: Not visible from outside
e(e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
f(f) Assessing the effectiveness of security measures: Not visible from outside
g(g) Cyber hygiene and security training: Not visible from outside
h(h) Cryptography and encryption: Partly checked
i(i) HR security, access control and asset management: One indicator
j(j) Multi-factor authentication and secured communications: Not visible from outside
Partly checked
One indicator
Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
5 findings rated critical or high. Fix these first.
Security headers
Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.
High
Missing Strict-Transport-Security header
Forces HTTPS connections
What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"
This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended
€25per month
TLS certificates and expiry
DNS records
SPF, DKIM and DMARC
Security headers
GDPR and NIS2 posture
Exposed services
Third-party trackers
Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
SSL/TLS
72
Security headers
25
Email security
75
DNS health
65
Network security
40
GDPR outside view
68
Average
58
Not counted
NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
The certificate is not trusted by browsers
The website is not served over HTTPS
A database, remote desktop, file-sharing or Telnet service is reachable from the internet
The page loads a script from a compromised source
The domain registration has expired
SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Critical0–25
High26–49
Medium50–75
Low76–100
Breach exposure
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Dark web exposure
Add-on
Leaked records that mention pharmadeutschland.de, from OffSeq Breach.
No leaked records found
Breach holds no records for pharmadeutschland.de right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
Pharma Deutschland holds a leading market position as a key industry association in the German healthcare sector. Its business model centers on member representation, policy advocacy, and knowledge dissemination. The association leverages a broad partnership ecosystem, including digital platforms and social media, to maintain visibility and influence. Revenue streams likely include membership fees, event hosting, and publication sales. The website's content and structure indicate a mature organization with a focus on transparency and member engagement. Growth indicators include active event calendars and educational offerings. The association's presence in Bonn, Berlin, and Brussels underscores its strategic positioning within national and EU regulatory environments.
Security posture
The website exhibits a mature security posture with mandatory HTTPS and secure login forms using AJAX. The integration of a consent management platform ensures compliance with privacy regulations. No critical vulnerabilities or exposed sensitive data were detected in the HTML content. However, the absence of explicit security headers like Content-Security-Policy and X-Frame-Options suggests room for enhancement. The use of self-hosted Matomo analytics reduces reliance on third-party trackers, improving privacy. Incident response and security policy documentation are not publicly visible, which could be improved to demonstrate readiness. Overall, the site balances usability and security effectively but should consider additional header implementations and regular security audits.
Recommendations
Implement and enforce security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to mitigate common web vulnerabilities.
Publish a clear security policy and incident response plan accessible to users and stakeholders to enhance transparency and preparedness.
Regularly update TYPO3 CMS and all extensions to patch known vulnerabilities and maintain a secure environment.
Enhance accessibility features to improve compliance with standards and broaden user inclusivity.
Continue monitoring third-party scripts and consent mechanisms to ensure ongoing GDPR compliance and user trust.
Automated reading of the public site. Ratings are indicative.
Business
Company
Pharma Deutschland e.V.
Description
Pharma Deutschland ist mit mehr als 400 Mitgliedsunternehmen der mitgliederstärkste Verband der pharmazeutischen Industrie in Deutschland. Die Pharmaindustrie ist eine gesunde, permanent innovative, hochrelevante Industrie mit starker Wertschöpfung. Pharma Deutschland sorgt dafür, dass die Pharmabranche im Gesundheitsbereich, in der Politik und der Öffentlichkeit als Leitbranche wahrgenommen wird.
Key services
Advocacy and representation, Publications and studies, Consulting and expertise, Seminars and training, Newsletter and member area
Content quality
good
Branding
consistent
Technology
Stack
TYPO3 CMS, jQuery, Usercentrics Consent Management Platform, Flockler social media embed, Matomo Analytics (self-hosted)
Frameworks
TYPO3 CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good
Security
Observed score
85/100
Good practices seen
HTTPS enforced
Use of consent management platform for privacy compliance
Login form uses AJAX with error handling
No exposed sensitive data in HTML
Analytics and tracking
Services
Matomo Analytics (self hosted)
Tracking level
moderate
Privacy practices
good
Advertising
Tracking pixels
Matomo (self hosted)
Marketing tools
Usercentrics Consent Management Platform, Flockler social media embeds
Transparency
good
Site quality
Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high
Key observations
Website is fully accessible with no blocking or WAF challenges.
Uses modern CMS TYPO3 with professional design and clear navigation.
Strong focus on pharmaceutical industry association content and member services.
Includes GDPR-compliant privacy and cookie policies with consent management.
Multiple contact methods and physical office addresses in Germany and Brussels.
Social media presence on Instagram, LinkedIn, and YouTube.
Self-hosted Matomo analytics for privacy-friendly tracking.
No signs of suspicious or malicious content.
Technical notes
Notes
The website is built on TYPO3 CMS, a robust and widely used content management system, indicating a solid technical foundation. It uses jQuery and integrates Usercentrics for consent management and Flockler for social media embedding, reflecting modern web practices. Hosting is provided by rzone.de, a reputable German hosting provider. Performance is moderate with responsive design and mobile optimization evident. SEO is supported by proper meta tags and hreflang attributes for multilingual support. Accessibility is basic but could be improved. The site uses self-hosted Matomo analytics, enhancing privacy. Overall, the technical infrastructure is stable and well-suited for the organization's needs, with opportunities for modernization and security hardening.
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Reviews of this site
Share your experience with pharmadeutschland.de. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review pharmadeutschland.de.